A novel mechanism that plays an all imperative role in long-term memory formation has been uncovered by scientists.
The findings from researchers at the Florida campus of The Scripps Research Institute shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
In the study, the scientists found that a main driver of memory formation is myosin II, a motor protein critical to cell movement and growth.
"Once we're able to do that, we can begin to develop potential treatments that could restore memory in people who suffer from cognitive disorders like Alzheimer's disease."
In the study, Rumbaugh and his colleagues showed that myosin II mediates a mechanical process that is part of the complex process of memory formation.
Specifically, myosin II links together the initiation of long-term potentiation, a process that enhances signal transmission between two neurons in the creation of memory; the stabilization of synaptic plasticity (the ability of synapses to maintain this enhanced transmission); and the reorganization of neurons' F-actin, a cellular polymer that enables growth of synapses.
"Stimulation in the brain turns on these myosin motors and this triggers the growth of F-actin that ultimately solidifies the enhancement of neuronal communication," Rumbaugh said.
"Growth and strengthening of synapses is a process that the brain uses to record our experiences. We are just now beginning to understand the physical substrates within synapses that enable the storage of our life experiences."
He added that the role of F-actin described in the study is consistent with the long-standing idea that long-term potentiation is dependent on changes to the synaptic architecture, suggesting the dynamic reorganization triggered by myosin II represents an early step in information encoding.
"Many parallel brain processes have to be activated to store information. If any one of them is disrupted, the information doesn't get stabilized and the memory is lost. Myosin II is a central regulator of this process and if you could pharmacologically control myosin II, you could potentially regulate memories at will," he said.
The study was published as the cover story of the journal Neuron on August 26, 2010.